Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof

A technology of transfection efficiency and targeting, which is applied in the direction of non-active ingredients of polymer compounds, gene therapy, drug combination, etc., can solve the problems of poor targeting and low transfection efficiency, and achieve strong targeting and high efficiency. To modify and reduce the effect of non-specific side effects

Inactive Publication Date: 2012-06-27
INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to overcome the problems of poor gene/drug carrier targeting and low transfecti

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
  • Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
  • Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Synthesis and Characterization of Polypeptide TATp-Cys-LHRHp

[0061] Apply peptide synthesizer, adopt solid-phase peptide synthesis technology to carry out peptide synthesis, the result of mass spectrometry analysis shows that its molecular ion peak is 2657 (see figure 1 ), consistent with the expected molecular weight of the polypeptide, analyzed by HPLC, its purity is greater than 99% (see figure 2 )

Embodiment 2

[0063] Preparation of TATp-Cys-LHRHp gene-carrying nanoparticles

[0064] Dissolve the polypeptide carrier (TATp-Cys-LHRHp) and plasmid DNA in water to prepare an aqueous solution, and then place the two aqueous solutions in a water bath at 37°C for 10 minutes; N / P (is it a molar ratio?) ratio of 10:1 The two solutions were quickly mixed and vortexed for 50 seconds to obtain TATp-Cys-LHRHp gene-carrying nanoparticles. The average particle size of the nanoparticles is about 82nm, and the zeta potential is 26mV.

[0065] N / P can be selected from 2:1 to 20:1, and the shaking time is selected from 40 to 60 seconds. The obtained TATp-Cys-LHRHp gene-carrying nanoparticles have an average particle size of about 70-90 nm and a zeta potential of 20-40mY.

Embodiment 3

[0067] Cell transfection experiments of TATp-Cys-LHRHp gene-carrying nanoparticles

[0068] According to the preparation method of TATp-Cys-LHRHp gene-loaded nanoparticles in Example 2, TATp-Cys-LHRHp gene-loaded nanoparticles with an N / P ratio of 10:1 were prepared, and then the nanoparticles were transfected into human liver cancer cells BEL-7402 and For normal human liver cells LO2, the amount of transfected nanoparticles is 5 μg DNA / ml calculated by DNA. After 24 hours of transfection, the results of high-content live cell imaging show that the nanoparticles have strong targeting effect on liver cancer cells BEL-7402 , its transfection efficiency is high, but the normal liver cell LO2 transfection efficiency is very low.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a polypeptide carrier used for improving targeting ability and transfection efficiency of a medicine/gene. The polypeptide carrier has a structure represented by a formula (I): TATp-Cys-LHRHp (I), wherein TATp is a TAT fragment of HIV, Cys is Cysteine, LHRHp is an analogue of luteinizing hormone releasing hormone LHRH. The polypeptide carrier provided by the invention carries a large amount of positive charges. The polypeptide carrier has good water-solubility and high targeting ability aiming at sexual hormone dependent tumor and liver cancer. The carrier can directlycarry negatively charged nucleic acid or medicine, and mediate the nucleic acid or medicine into cells. Also, the carrier can be used for modifying other gene or medicine carriers, such that tumor targeting abilities and transfection efficiency of the gene or medicine carriers can be improved. Therefore, a novel carrier is provided for gene/medicine delivering.

Description

technical field [0001] The invention belongs to the technical field of biological materials, and specifically relates to a polypeptide carrier for improving drug / gene targeting and transfection efficiency and its application. Background technique [0002] Cancer is one of the most common causes of morbidity and mortality today, with more than 10 million new cases and 6.2 million deaths worldwide every year. The latest statistics show that in the past two decades, the cancer mortality rate in China has increased by nearly 30%, and one out of every four or five deaths is due to cancer, ranking first among the causes of death. However, due to the lack of targeting, current cancer chemotherapy drugs kill cancer cells and cause normal cells to die, resulting in severe systemic side effects for patients. Therefore, the development of efficient targeted gene / drug carriers plays a vital role in tumor therapy. [0003] Cell penetrating peptides are a class of polypeptides that can ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K19/00C12N15/87A61K47/42A61K48/00A61P35/00C08B37/08
Inventor 冷希岗刘兰霞朱敦皖董霞宋丽萍
Owner INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap